Access to Primary Care for People With Opioid Use Disorder
NCT05484609 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 383
Last updated 2022-08-02
Summary
Background: Access to high quality primary care is essential for health, particularly for vulnerable populations. Research indicates, however, that people with opioid use disorder (OUD), are less likely than others to have a primary care provider. The reasons are unclear, but may be related to patient factors, system barriers and provider factors, including discrimination.
Research goal: Our primary goal is to determine if discrimination by primary care physicians plays a role in poor access to primary care for those in treatment for OUD. The answers will help researchers and policy-makers find ways to improve access to primary care for this vulnerable population.
Research question: Are people in treatment for OUD less likely to be offered a new patient appointment with a physician compared to those in treatment for diabetes? Overall study design: In this randomized controlled trial (RCT), the investigators will make unannounced phone calls to primary care physicians' practices to ask for a new patient appointment. Physicians will be randomly assigned to one of two clinical scenarios: a patient with diabetes, or a patient in treatment for OUD. Our outcome measure is an unconditional offer of a new patient appointment with the physician contacted or with another physician at the same practice. In an secondary analysis the investigators will determine the impact of physician gender, years in practice, rurality and model of care on offers of a new patient appointment.
Participants: Randomly-selected primary care physicians in Ontario. Data analysis methods: The investigators will use chi-squared test and logistic regression to determine if there is a statistically and clinically significant difference in the proportions of offering a new patient appointment between the two clinical scenarios.
Conditions
- Access to Primary Care
Interventions
- OTHER
-
OUD scenario
The patient actor will make unannounced phone calls to family physicians asking for a new patient appointment. The patient actor will play the role of a patient with opioid use disorder undergoing methadone treatment with an addiction physician.
- OTHER
-
Diabetes scenario
The patient actor will make unannounced phone calls to family physicians asking for a new patient appointment. The patient actor will play the role of patient with diabetes in treatment with an endocrinologist.
Sponsors & Collaborators
-
Women's College Hospital
lead OTHER
Principal Investigators
-
Sheryl M Spithoff, MD MSc · Women's College Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-06-01
- Primary Completion
- 2021-09-30
- Completion
- 2021-09-30
Countries
- Canada
More Related Trials
-
A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain
NCT02751762 ·Status: COMPLETED
-
Sensory Outcomes in Active Substance Users
NCT06639438 ·Status: RECRUITING
-
PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study
NCT06608459 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Long-Term Opioid Therapy in Chronic Non-Cancer Pain: Risks and Benefits
NCT06063902 ·Status: ENROLLING_BY_INVITATION
-
The Potential of Oxytocin to Reduce Opioid Abuse Liability and Pain Among Older Adults
NCT05761860 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Current Opioid-User Population
NCT04601480 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Health Plan Initiative to Mitigate Chronic Opioid Therapy Risks
NCT02224508 ·Status: COMPLETED
-
The Impact of Co-Dispensing Naloxone to Patients Prescribed Chronic Opioid Therapy
NCT03337100 ·Status: COMPLETED ·Phase: NA
-
Reducing the Abuse of Opioids in Drug Users
NCT03837860 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
AESOPS Trial 2 (AESOPS-2): Availability of Opioid Harm
NCT04758637 ·Status: COMPLETED ·Phase: NA
-
OMAR Opioid Use Disorder
NCT05683184 ·Status: RECRUITING ·Phase: PHASE1
-
The Impact of a Web-Based Naloxone Intervention Under Standing Orders to Patients Prescribed Chronic Opioid Therapy
NCT03337009 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Determining the Feasibility of Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Opioids
NCT05300581 ·Status: COMPLETED ·Phase: NA
-
Preventing Opioid Overdose Deaths by Empowering Pharmacists to Dispense Naloxone
NCT05093309 ·Status: COMPLETED ·Phase: NA
-
Low-dose Versus a High-dose Sublingual Buprenorphine Induction
NCT05944952 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Incidence and Predictors of Opioid Overdose and Death Among Long-Term Users of Opioid Analgesics
NCT02662153 ·Status: COMPLETED
-
Evaluation of Pharmacy Students' Perception of Opioid / Opiate Dependence
NCT03859778 ·Status: COMPLETED
-
Increasing Naloxone Access for Persons Who Use Opioids
NCT04303000 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of a Computerized Opioid Overdose Prevention Program
NCT02040077 ·Status: COMPLETED ·Phase: NA
-
A Pragmatic Randomized Control Trial Comparing Models of Care in the Management of Prescription Opioid Misuse
NCT03033732 ·Status: COMPLETED ·Phase: PHASE4
-
Overdose Risk Management and Naloxone
NCT03933345 ·Status: UNKNOWN
-
Long-Acting Injectable Naltrexone Treatment of Alcohol Dependence in Primary Care vs. in Specialized Chemical Dependence Treatment: A Pilot Trial
NCT00461890 ·Status: TERMINATED ·Phase: PHASE4
-
Prescription Opioid Discontinuation: Honoring Patient Insights and Experience to Support Safe and Caring Transitions -- Decision Aid Pilot
NCT07202026 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Effect of Buprenorphine/Naloxone Continuation on Pain Control and Opioid Use
NCT03266445 ·Status: UNKNOWN ·Phase: PHASE4